Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical Revenue

In the year 2024, Collegium Pharmaceutical had annual revenue of $631.45M with 11.41% growth. Collegium Pharmaceutical had revenue of $181.95M in the quarter ending December 31, 2024, with 21.51% growth.

• Revenue (ttm): $631.45M
• Revenue Growth: +11.41%
• P/S Ratio: 1.52
• Revenue / Employee: $1,768,765
• Employees: 357
• Market Cap: 942.36M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	631.45M	64.68M	11.41%
Dec 31, 2023	566.77M	102.83M	22.17%
Dec 31, 2022	463.93M	187.07M	67.56%
Dec 31, 2021	276.87M	-33.15M	-10.69%
Dec 31, 2020	310.02M	13.32M	4.49%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.